PR

Padmaja Rani Velecheti

Active Director Director DIN 02348835
DIN 02348835 First appointment Dec 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Dec 2008
Shareholding value •••• Premium profile

About Padmaja Rani Velecheti

Data last updated:

Padmaja Rani Velecheti is a Director at Mahalakshmi Laboratories Private Limited (since 2008), Additional Director at Geoviq Lifesciences Private Limited (since 2023) and Director at Sri Sujala Drugs & Intermediates Private Limited (since 2021). The companies operate in Pharma and Chemicals and Materials. The largest current company by reported revenue is Mahalakshmi Laboratories Private Limited at ₹33.56 Cr (FY 2025). Earlier, Padmaja Rani Velecheti was a Director at Vsk Labs Private Limited (2021–2023) and Director at Newatom Labs Private Limited (2021–2023) and 1 more.

DIN 02348835
Primary Designation Director
Industry Pharma
First Appointment 31 Dec 2008
Oldest Company Age 19 yrs
Largest company Mahalakshmi Laboratories Private Limited · ₹33.56 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Dec 20082006₹33.56 Cr (FY 2025)Active
Geoviq Lifesciences Private Limited U52390TG2019PTC133430
Additional Director04 Jul 20232019Active
Director25 Mar 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vsk Labs Private Limited U24290TG2021PTC158329
Director29 Dec 20212021Active
Newatom Labs Private Limited U24239TG2021PTC149266
Director04 Mar 20212021₹52,170 (FY 2025)Active
Medchem Organics Private Limited U24110TG2007PTC053487
Additional Director31 Dec 20082007₹7 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sri Sujala Drugs & Intermediates Private Limited
Mahalakshmi Laboratories Private Limited
Geoviq Lifesciences Private Limited
Vsk Labs Private Limited
Premium access

Shareholding and investment profile for Padmaja Rani Velecheti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Padmaja Rani Velecheti

Padmaja Rani Velecheti currently holds 3 directorships: Mahalakshmi Laboratories Private Limited (Director, since 31 Dec 2008, revenue ₹33.56 Cr (FY 2025)); Geoviq Lifesciences Private Limited (Additional Director, since 04 Jul 2023); Sri Sujala Drugs & Intermediates Private Limited (Director, since 25 Mar 2021).

Padmaja Rani Velecheti was first appointed on 31 Dec 2008 as Director at Mahalakshmi Laboratories Private Limited. The most recent appointment on record is 04 Jul 2023 at Geoviq Lifesciences Private Limited.

Padmaja Rani Velecheti held 3 earlier board appointments: Vsk Labs Private Limited (Director, 29 Dec 2021 to 12 Jun 2023); Newatom Labs Private Limited (Director, 04 Mar 2021 to 12 Jun 2023); Medchem Organics Private Limited (Additional Director, 31 Dec 2008 to 22 Jun 2011).

The current boards of Padmaja Rani Velecheti's companies include Guntupalli Pratyusha (Mahalakshmi Laboratories Private Limited), Jagannadham Bevara (Mahalakshmi Laboratories Private Limited), Rama Krishna Battula (Mahalakshmi Laboratories Private Limited), Srikanth Velicheti (Mahalakshmi Laboratories Private Limited), Velecheti Sureshbabu (Mahalakshmi Laboratories Private Limited), Balakrishna Rao Madavaram (Geoviq Lifesciences Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available